SFA
EBS icon

Semmax Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Semmax Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-190
Closed -$10K – 368
2019
Q1 		$10K Sell
190
-316
-62% -$18.6K 0.01% 321
2018
Q4 		$30K Buy
+506
New +$32.6K 0.02% 236

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Semmax Financial Advisors's EBS Position: Q2 2019 in Review

Semmax Financial Advisors sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 190 shares — an estimated $10K sold.

Semmax Financial Advisors first reported a position in EBS in Q4 2018 and held it in 2 quarters. The position peaked at $30K in Q4 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Semmax Financial Advisors reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Semmax Financial Advisors sold 190 Emergent Biosolutions shares in Q2 2019, an estimated $10K.
  • Semmax Financial Advisors first reported a position in Emergent Biosolutions in Q4 2018 and held it in 2 quarters.
  • Semmax Financial Advisors's Emergent Biosolutions position peaked at $30K in Q4 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Semmax Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.